Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC

NCT05223244 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Interstitial Cystitis
Painful Bladder Syndrome

Interventions

DRUG: bupivacaine, triamcinolone, and heparin (BTH)
DRUG: dimethyl sulfoxide (DMSO)

Sponsor

Endeavor Health